Abstract | OBJECTIVE: To evaluate the impact of fertility-saving surgery and adjuvant chemotherapy on survival and fertility of young patients with ovarian malignant tumors. METHODS: RESULTS: Fifty-nine among 64 patients have been alive up to now (92%). The overall survival rate for ovarian epithelial malignancies, malignant germ cell tumors and sexual cord mesenchymal tumors were 95% (21/22), 89% (34/38) and 4/4, respectively. Fifteen patients received second operation and recurrence was found in 6 patients. Among the 59 surviving patients, 53 had normal menstruation. Thirteen patients among 20 patients who wanted to get pregnant had 15 pregnancies and 9 successful deliveries. CONCLUSIONS: The management of fertility-saving surgery on patients with ovarian malignant germ cell tumors, whatever the stagings are, is a safe option. For patients with ovarian epithelial carcinomas, fertility-saving surgery is only indicated for low-stage (stage I), high-grade (G1), and patients who hope to maintain fertility function eagerly. Cisplatinum-based combination chemotherapy is necessary. Standardized chemotherapy has no effect on fertility function.
|
Authors | Ming-rong Xi, Min-min Hou, Ze-yi Cao, Chong-shu Zhang, Zhi-lan Peng, Hong-jing Wang, Ai Zheng |
Journal | Zhonghua fu chan ke za zhi
(Zhonghua Fu Chan Ke Za Zhi)
Vol. 41
Issue 4
Pg. 233-6
(Apr 2006)
ISSN: 0529-567X [Print] China |
PMID | 16759456
(Publication Type: Evaluation Study, Journal Article)
|
Topics |
- Adolescent
- Adult
- Antineoplastic Combined Chemotherapy Protocols
(therapeutic use)
- Chemotherapy, Adjuvant
- Child
- Female
- Fertility
- Follow-Up Studies
- Germinoma
(drug therapy, mortality, surgery)
- Humans
- Lymph Node Excision
- Neoplasm Recurrence, Local
- Neoplasm Staging
- Ovarian Neoplasms
(drug therapy, mortality, surgery)
- Ovariectomy
(methods)
- Pregnancy
- Pregnancy Outcome
- Reproducibility of Results
- Retrospective Studies
- Survival Rate
- Treatment Outcome
|